Top

Published in:

01-04-2020 | Magnetic Resonance Imaging | Special Section: Distinguished Papers from JSAR

Imaging features of adrenal gland masses in the pediatric population

Authors: Abdelrahman K. Hanafy, Bilal Mujtaba, Alicia M. Roman-Colon, Khaled M. Elsayes, Douglas Harrison, Nisha S. Ramani, Steven G. Waguespack, Ajaykumar C. Morani

Published in: Abdominal Radiology | Issue 4/2020

Abstract

The spectrum of adrenal masses in the pediatric population markedly differs from that in the adult population. Imaging plays a crucial role in detecting adrenal masses, differentiating malignant from benign lesions, recognizing extra-adrenal lesions in the suprarenal fossa, and directing further management. Ultrasound is the primary imaging modality of choice for the evaluation of adrenal masses in the neonatal period, whereas MRI or CT is used as a problem-solving tool. In older children, computed tomography or magnetic resonance imaging is often required after initial sonographic evaluation for further characterization of a lesion. Herein, we discuss the salient imaging features along with pathophysiology and clinical features of pediatric adrenal masses.

Sargar KM, Khanna G, Hulett Bowling R (2017) Imaging of Nonmalignant Adrenal Lesions in Children. Radiographics: a review publication of the Radiological Society of North America, Inc 37 (6):1648–1664. https://doi.org/10.1148/rg.2017170043 CrossRef

Flynt KA, Dillman JR, Davenport MS, Smith EA, Else T, Strouse PJ, Caoili EM (2015) Pediatric adrenocortical neoplasms: can imaging reliably discriminate adenomas from carcinomas? Pediatric radiology 45 (8):1160–1168. https://doi.org/10.1007/s00247-015-3308-x CrossRefPubMed

Swift CC, Eklund MJ, Kraveka JM, Alazraki AL (2018) Updates in Diagnosis, Management, and Treatment of Neuroblastoma. Radiographics: a review publication of the Radiological Society of North America, Inc 38 (2):566–580. https://doi.org/10.1148/rg.2018170132

Balassy C, Navarro OM, Daneman A (2011) Adrenal masses in children. Radiologic clinics of North America 49 (4):711–727, vi. https://doi.org/10.1016/j.rcl.2011.05.001

Dong SZ, Zhu M, Bulas D (2019) Techniques for minimizing sedation in pediatric MRI. J Magn Reson Imaging . https://doi.org/10.1002/jmri.26703 CrossRefPubMed

Guimarães MD, Noschang J, Teixeira SR, Santos MK, Lederman HM, Tostes V, Kundra V, Oliveira AD, Hochhegger B, Marchiori E (2017) Whole-body MRI in pediatric patients with cancer. Cancer imaging: the official publication of the International Cancer Imaging Society 17 (1):6. https://doi.org/10.1186/s40644-017-0107-7 CrossRef

Walker B, Conklin HM, Anghelescu DL, Hall LP, Reddick WE, Ogg R, Jacola LM (2018) Parent perspectives and preferences for strategies regarding nonsedated MRI scans in a pediatric oncology population. Support Care Cancer 26 (6):1815–1824. https://doi.org/10.1007/s00520-017-4009-9 CrossRefPubMed

Rajaraman P, Sir Craft AW, Parker L, Berrington de González A (2012) Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study. Lancet (London, England) 380 (9840):499–505. https://doi.org/10.1016/s0140-6736(12)60815-0 CrossRef

Brody AS, Frush DP, Huda W, Brent RL (2007) Radiation risk to children from computed tomography. Pediatrics 120 (3):677–682. https://doi.org/10.1542/peds.2007-1910 CrossRefPubMed

10.

Lloyd RV OR, Klöppel G, Rosai J (2017) WHO classification of tumours of endocrine organs. World Health Organization Classification of Tumours; tenth volume, 4th edition. Lyon: International Agency for Research on Cancer (IARC), France

11.

Lenders JW, Eisenhofer G, Mannelli M, Pacak K (2005) Phaeochromocytoma. Lancet (London, England) 366 (9486):665–675. https://doi.org/10.1016/s0140-6736(05)67139-5 CrossRef

12.

Neumann HP, Young WF, Jr., Krauss T, Bayley JP, Schiavi F, Opocher G, Boedeker CC, Tirosh A, Castinetti F, Ruf J, Beltsevich D, Walz M, Groeben HT, von Dobschuetz E, Gimm O, Wohllk N, Pfeifer M, Lourenco DM, Jr., Peczkowska M, Patocs A, Ngeow J, Makay O, Shah NS, Tischler A, Leijon H, Pennelli G, Villar Gomez de Las Heras K, Links TP, Bausch B, Eng C (2018) 65 YEARS OF THE DOUBLE HELIX: Genetics informs precision practice in the diagnosis and management of pheochromocytoma. Endocrine-related cancer 25 (8):T201–T219. https://doi.org/10.1530/erc-18-0085 CrossRefPubMed

13.

Ross JH (2000) Pheochromocytoma. Special considerations in children. The Urologic clinics of North America 27 (3):393–402

14.

Mittendorf EA, Evans DB, Lee JE, Perrier ND (2007) Pheochromocytoma: advances in genetics, diagnosis, localization, and treatment. Hematology/oncology clinics of North America 21 (3):509–525; ix. https://doi.org/10.1016/j.hoc.2007.04.012

15.

Bausch B, Wellner U, Bausch D, Schiavi F, Barontini M, Sanso G, Walz MK, Peczkowska M, Weryha G, Dall’igna P, Cecchetto G, Bisogno G, Moeller LC, Bockenhauer D, Patocs A, Racz K, Zabolotnyi D, Yaremchuk S, Dzivite-Krisane I, Castinetti F, Taieb D, Malinoc A, von Dobschuetz E, Roessler J, Schmid KW, Opocher G, Eng C, Neumann HP (2014) Long-term prognosis of patients with pediatric pheochromocytoma. Endocrine-related cancer 21 (1):17–25. https://doi.org/10.1530/erc-13-0415 CrossRefPubMed

16.

Waguespack SG, Rich T, Grubbs E, Ying AK, Perrier ND, Ayala-Ramirez M, Jimenez C (2010) A current review of the etiology, diagnosis, and treatment of pediatric pheochromocytoma and paraganglioma. The Journal of clinical endocrinology and metabolism 95 (5):2023–2037. https://doi.org/10.1210/jc.2009-2830 CrossRefPubMed

17.

Muth A, Crona J, Gimm O, Elmgren A, Filipsson K, Stenmark Askmalm M, Sandstedt J, Tengvar M, Tham E (2019) Genetic testing and surveillance guidelines in hereditary pheochromocytoma and paraganglioma. Journal of internal medicine 285 (2):187-204. https://doi.org/10.1111/joim.12869 CrossRefPubMed

18.

Lenders JW, Duh QY, Eisenhofer G, Gimenez-Roqueplo AP, Grebe SK, Murad MH, Naruse M, Pacak K, Young WF, Jr. (2014) Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. The Journal of clinical endocrinology and metabolism 99 (6):1915-1942. https://doi.org/10.1210/jc.2014-1498 CrossRefPubMed

19.

Tischler AS (2008) Pheochromocytoma and extra-adrenal paraganglioma: updates. Archives of pathology & laboratory medicine 132 (8):1272–1284. https://doi.org/10.1043/1543-2165(2008)132%5b1272:paepu%5d2.0.co;2

20.

Young WF, Jr. (2016) Endocrine Hypertension. In: Melmed S, Polonsky KS, Larsen PR, Kronenberg HM (eds) Williams Textbook of Endocrinology. 13 edn. Elsevier, Philadelphia, PA, pp 556–588

21.

Paterson A (2002) Adrenal pathology in childhood: a spectrum of disease. European radiology 12 (10):2491–2508. https://doi.org/10.1007/s00330-002-1311-8 CrossRefPubMed

22.

Taffel M, Haji-Momenian S, Nikolaidis P, Miller FH (2012) Adrenal imaging: a comprehensive review. Radiologic clinics of North America 50 (2):219–243, v. https://doi.org/10.1016/j.rcl.2012.02.009

23.

Havekes B, Romijn JA, Eisenhofer G, Adams K, Pacak K (2009) Update on pediatric pheochromocytoma. Pediatric nephrology (Berlin, Germany) 24 (5):943–950. https://doi.org/10.1007/s00467-008-0888-9 CrossRef

24.

Jain A, Baracco R, Kapur G (2019) Pheochromocytoma and paraganglioma-an update on diagnosis, evaluation, and management. Pediatric nephrology (Berlin, Germany). https://doi.org/10.1007/s00467-018-4181-2

25.

Blake MA, Cronin CG, Boland GW (2010) Adrenal imaging. AJR American journal of roentgenology 194 (6):1450-1460. https://doi.org/10.2214/ajr.10.4547 CrossRefPubMed

26.

Johnson PT, Horton KM, Fishman EK (2009) Adrenal mass imaging with multidetector CT: pathologic conditions, pearls, and pitfalls. Radiographics: a review publication of the Radiological Society of North America, Inc 29 (5):1333–1351. https://doi.org/10.1148/rg.295095027

27.

Pacak K, Eisenhofer G, Ahlman H, Bornstein SR, Gimenez-Roqueplo AP, Grossman AB, Kimura N, Mannelli M, McNicol AM, Tischler AS (2007) Pheochromocytoma: recommendations for clinical practice from the First International Symposium. October 2005. Nature clinical practice Endocrinology & metabolism 3 (2):92–102. https://doi.org/10.1038/ncpendmet0396 CrossRef

28.

Kroiss AS (2019) Current status of functional imaging in neuroblastoma, pheochromocytoma, and paraganglioma disease. Wiener medizinische Wochenschrift (1946) 169 (1–2):25–32. https://doi.org/10.1007/s10354-018-0658-7 CrossRef

29.

Timmers HJ, Taieb D, Pacak K (2012) Current and future anatomical and functional imaging approaches to pheochromocytoma and paraganglioma. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 44 (5):367–372. https://doi.org/10.1055/s-0031-1299712

30.

Chang CA, Pattison DA, Tothill RW, Kong G, Akhurst TJ, Hicks RJ, Hofman MS (2016) (68)Ga-DOTATATE and (18)F-FDG PET/CT in Paraganglioma and Pheochromocytoma: utility, patterns and heterogeneity. Cancer imaging: the official publication of the International Cancer Imaging Society 16 (1):22. https://doi.org/10.1186/s40644-016-0084-2 CrossRef

31.

Hofman MS, Lau WF, Hicks RJ (2015) Somatostatin receptor imaging with 68 Ga DOTATATE PET/CT: clinical utility, normal patterns, pearls, and pitfalls in interpretation. Radiographics: a review publication of the Radiological Society of North America, Inc 35 (2):500–516. https://doi.org/10.1148/rg.352140164

32.

Plouin PF, Amar L, Dekkers OM, Fassnacht M, Gimenez-Roqueplo AP, Lenders JW, Lussey-Lepoutre C, Steichen O (2016) European Society of Endocrinology Clinical Practice Guideline for long-term follow-up of patients operated on for a phaeochromocytoma or a paraganglioma. European journal of endocrinology 174 (5):G1–g10. https://doi.org/10.1530/eje-16-0033 CrossRefPubMed

33.

Melo-Leite AF, Elias PC, Teixeira SR, Tucci S, Barros GE, Antonini SR, Muglia VF, Elias J (2017) Adrenocortical neoplasms in adulthood and childhood: distinct presentation. Review of the clinical, pathological and imaging characteristics. Journal of pediatric endocrinology & metabolism: JPEM 30 (3):253–276. https://doi.org/10.1515/jpem-2016-0080

34.

Wieneke JA, Thompson LD, Heffess CS (2003) Adrenal cortical neoplasms in the pediatric population: a clinicopathologic and immunophenotypic analysis of 83 patients. The American journal of surgical pathology 27 (7):867–881CrossRef

35.

Hanna AM, Pham TH, Askegard-Giesmann JR, Grams JM, Iqbal CW, Stavlo P, Moir CR (2008) Outcome of adrenocortical tumors in children. Journal of pediatric surgery 43 (5):843–849. https://doi.org/10.1016/j.jpedsurg.2007.12.022 CrossRefPubMed

36.

Rescorla FJ (2006) Malignant adrenal tumors. Seminars in pediatric surgery 15 (1):48–56. https://doi.org/10.1053/j.sempedsurg.2005.11.008 CrossRefPubMed

37.

Bonnet-Serrano F, Bertherat J (2018) Genetics of tumors of the adrenal cortex. Endocrine-related cancer 25 (3):R131–r152. https://doi.org/10.1530/erc-17-0361 CrossRefPubMed

38.

MacFarland SP, Mostoufi-Moab S, Zelley K, Mattei PA, States LJ, Bhatti TR, Duffy KA, Brodeur GM, Kalish JM (2017) Management of adrenal masses in patients with Beckwith-Wiedemann syndrome. Pediatric blood & cancer 64 (8). https://doi.org/10.1002/pbc.26432

39.

Challis BG, Kandasamy N, Powlson AS, Koulouri O, Annamalai AK, Happerfield L, Marker AJ, Arends MJ, Nik-Zainal S, Gurnell M (2016) Familial Adrenocortical Carcinoma in Association With Lynch Syndrome. The Journal of clinical endocrinology and metabolism 101 (6):2269–2272. https://doi.org/10.1210/jc.2016-1460 CrossRefPubMedPubMedCentral

40.

Grajo JR, Paspulati RM, Sahani DV, Kambadakone A (2016) Multiple Endocrine Neoplasia Syndromes: A Comprehensive Imaging Review. Radiologic clinics of North America 54 (3):441–451. https://doi.org/10.1016/j.rcl.2015.12.001 CrossRefPubMed

41.

Amadou A, Waddington Achatz MI, Hainaut P (2018) Revisiting tumor patterns and penetrance in germline TP53 mutation carriers: temporal phases of Li-Fraumeni syndrome. Current opinion in oncology 30 (1):23–29. https://doi.org/10.1097/cco.0000000000000423 CrossRefPubMed

42.

Mylonas KS, Schizas D, Economopoulos KP (2017) Adrenal ganglioneuroma: What you need to know. World journal of clinical cases 5 (10):373–377. https://doi.org/10.12998/wjcc.v5.i10.373 CrossRefPubMedPubMedCentral

43.

Lonergan GJ, Schwab CM, Suarez ES, Carlson CL (2002) Neuroblastoma, ganglioneuroblastoma, and ganglioneuroma: radiologic-pathologic correlation. Radiographics: a review publication of the Radiological Society of North America, Inc 22 (4):911–934. https://doi.org/10.1148/radiographics.22.4.g02jl15911

44.

Shawa H, Elsayes KM, Javadi S, Morani A, Williams MD, Lee JE, Waguespack SG, Busaidy NL, Vassilopoulou-Sellin R, Jimenez C, Habra MA (2014) Adrenal ganglioneuroma: features and outcomes of 27 cases at a referral cancer centre. Clinical endocrinology 80 (3):342-347. https://doi.org/10.1111/cen.12320 CrossRefPubMed

45.

Rajiah P, Sinha R, Cuevas C, Dubinsky TJ, Bush WH, Jr., Kolokythas O (2011) Imaging of uncommon retroperitoneal masses. Radiographics: a review publication of the Radiological Society of North America, Inc 31 (4):949–976. https://doi.org/10.1148/rg.314095132

46.

Lin CY, Levy D, Higgins JPT, Kunder CA, Kao CS (2018) Adrenal Myelolipomas Involved by Plasma Cell Myeloma. American journal of clinical pathology 150 (5):406–414. https://doi.org/10.1093/ajcp/aqy068 CrossRefPubMed

47.

Sethi S, Thakur S, Jacques S, Aoun HD, Tranchida P (2018) Myelolipoma of the Pelvis: A Case Report and Review of Literature. Frontiers in oncology 8:251. https://doi.org/10.3389/fonc.2018.00251 CrossRefPubMedPubMedCentral

48.

Lattin GE, Jr., Sturgill ED, Tujo CA, Marko J, Sanchez-Maldonado KW, Craig WD, Lack EE (2014) From the radiologic pathology archives: Adrenal tumors and tumor-like conditions in the adult: radiologic-pathologic correlation. Radiographics: a review publication of the Radiological Society of North America, Inc 34 (3):805–829. https://doi.org/10.1148/rg.343130127

49.

Korivi BR, Elsayes KM, de Castro SF (2015) An update of practical CT adrenal imaging: what physicians need to know. Curr Radiol Rep 3 (4):1–11CrossRef

50.

Elsayes KM, Emad-Eldin S, Morani AC, Jensen CT (2018) Practical Approach to Adrenal Imaging. The Urologic clinics of North America 45 (3):365–387. https://doi.org/10.1016/j.ucl.2018.03.005 CrossRefPubMed

51.

Rha SE, Byun JY, Jung SE, Chun HJ, Lee HG, Lee JM (2003) Neurogenic tumors in the abdomen: tumor types and imaging characteristics. Radiographics: a review publication of the Radiological Society of North America, Inc 23 (1):29–43. https://doi.org/10.1148/rg.231025050

52.

London WB, Castleberry RP, Matthay KK, Look AT, Seeger RC, Shimada H, Thorner P, Brodeur G, Maris JM, Reynolds CP, Cohn SL (2005) Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the Children’s Oncology Group. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 23 (27):6459–6465. https://doi.org/10.1200/jco.2005.05.571 CrossRef

53.

Kushner BH (2004) Neuroblastoma: a disease requiring a multitude of imaging studies. Journal of nuclear medicine: official publication, Society of Nuclear Medicine 45 (7):1172–1188

54.

Bittman ME, Lee EY, Restrepo R, Eisenberg RL (2013) Focal adrenal lesions in pediatric patients. AJR American journal of roentgenology 200 (6):W542–556. https://doi.org/10.2214/ajr.12.8677 CrossRefPubMed

55.

Woods WG, Gao RN, Shuster JJ, Robison LL, Bernstein M, Weitzman S, Bunin G, Levy I, Brossard J, Dougherty G, Tuchman M, Lemieux B (2002) Screening of infants and mortality due to neuroblastoma. The New England journal of medicine 346 (14):1041–1046. https://doi.org/10.1056/nejmoa012387 CrossRefPubMed

56.

Rudnick E, Khakoo Y, Antunes NL, Seeger RC, Brodeur GM, Shimada H, Gerbing RB, Stram DO, Matthay KK (2001) Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineuronal antibodies-a report from the Children’s Cancer Group Study. Medical and pediatric oncology 36 (6):612–622. https://doi.org/10.1002/mpo.1138 CrossRefPubMed

57.

Cohn SL, Pearson AD, London WB, Monclair T, Ambros PF, Brodeur GM, Faldum A, Hero B, Iehara T, Machin D, Mosseri V, Simon T, Garaventa A, Castel V, Matthay KK (2009) The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 27 (2):289–297. https://doi.org/10.1200/jco.2008.16.6785 CrossRef

58.

Barr EK, Applebaum MA (2018) Genetic Predisposition to Neuroblastoma. Children (Basel, Switzerland) 5 (9). https://doi.org/10.3390/children5090119

59.

Chen AM, Trout AT, Towbin AJ (2018) A review of neuroblastoma image-defined risk factors on magnetic resonance imaging. Pediatric radiology 48 (9):1337–1347. https://doi.org/10.1007/s00247-018-4117-9 CrossRefPubMed

60.

Brisse HJ, McCarville MB, Granata C, Krug KB, Wootton-Gorges SL, Kanegawa K, Giammarile F, Schmidt M, Shulkin BL, Matthay KK, Lewington VJ, Sarnacki S, Hero B, Kaneko M, London WB, Pearson AD, Cohn SL, Monclair T (2011) Guidelines for imaging and staging of neuroblastic tumors: consensus report from the International Neuroblastoma Risk Group Project. Radiology 261 (1):243–257. https://doi.org/10.1148/radiol.11101352 CrossRefPubMed

61.

Dumba M, Jawad N, McHugh K (2015) Neuroblastoma and nephroblastoma: a radiological review. Cancer imaging: the official publication of the International Cancer Imaging Society 15:5. https://doi.org/10.1186/s40644-015-0040-6 CrossRef

62.

He WG, Yan Y, Tang W, Cai R, Ren G (2017) Clinical and biological features of neuroblastic tumors: A comparison of neuroblastoma and ganglioneuroblastoma. Oncotarget 8 (23):37730-37739. https://doi.org/10.18632/oncotarget.17146 CrossRefPubMedPubMedCentral

63.

Gahr N, Darge K, Hahn G, Kreher BW, von Buiren M, Uhl M (2011) Diffusion-weighted MRI for differentiation of neuroblastoma and ganglioneuroblastoma/ganglioneuroma. European journal of radiology 79 (3):443–446. https://doi.org/10.1016/j.ejrad.2010.04.005 CrossRefPubMed

64.

Xu X, Sergi C (2016) Pediatric adrenal cortical carcinomas: Histopathological criteria and clinical trials. A systematic review. Contemporary clinical trials 50:37–44. https://doi.org/10.1016/j.cct.2016.07.011 CrossRefPubMed

65.

Sakoda A, Mushtaq I, Levitt G, Sebire NJ (2014) Clinical and histopathological features of adrenocortical neoplasms in children: retrospective review from a single specialist center. Journal of pediatric surgery 49 (3):410–415. https://doi.org/10.1016/j.jpedsurg.2013.09.008 CrossRefPubMed

66.

Wong KK, Miller BS, Viglianti BL, Dwamena BA, Gauger PG, Cook GJ, Colletti PM, Rubello D, Gross MD (2016) Molecular Imaging in the Management of Adrenocortical Cancer: A Systematic Review. Clinical nuclear medicine 41 (8):e368–382. https://doi.org/10.1097/rlu.0000000000001112 CrossRefPubMed

67.

Jasim S, Habra MA (2019) Management of Adrenocortical Carcinoma. Current oncology reports 21 (3):20. https://doi.org/10.1007/s11912-019-0773-7 CrossRefPubMed

68.

Ditkofsky N, Bradley N, Jeon P (2013) Horseshoe adrenal gland: a rare congenital anomaly. Surgical and radiologic anatomy: SRA 35 (8):749-754. https://doi.org/10.1007/s00276-013-1105-5 CrossRefPubMed

69.

Strouse PJ, Haller JO, Berdon WE, Rosovsky MA, Bellah RD, Barr M, Jr. (2002) Horseshoe adrenal gland in association with asplenia: presentation of six new cases and review of the literature. Pediatric radiology 32 (11):778–782. https://doi.org/10.1007/s00247-002-0773-9 CrossRefPubMed

70.

Goodman SN (1991) Neuroblastoma screening data. An epidemiologic analysis. American journal of diseases of children (1960) 145 (12):1415–1422

71.

Elsayes KM, Mukundan G, Narra VR, Lewis JS, Jr., Shirkhoda A, Farooki A, Brown JJ (2004) Adrenal masses: mr imaging features with pathologic correlation. Radiographics: a review publication of the Radiological Society of North America, Inc 24 Suppl 1:S73–86. https://doi.org/10.1148/rg.24si045514

72.

Morani AC, Jensen CT, Habra MA, Agrons MM, Menias CO, Wagner-Bartak NA, Shaaban AM, Roman-Colon AM, Elsayes KM (2019) Adrenocortical hyperplasia: a review of clinical presentation and imaging. Abdom Radiol (NY). https://doi.org/10.1007/s00261-019-02048-6 CrossRef

73.

Witchel SF (2017) Congenital Adrenal Hyperplasia. Journal of pediatric and adolescent gynecology 30 (5):520–534. https://doi.org/10.1016/j.jpag.2017.04.001 CrossRefPubMedPubMedCentral

74.

Chung EM, Biko DM, Schroeder JW, Cube R, Conran RM (2012) From the radiologic pathology archives: precocious puberty: radiologic-pathologic correlation. Radiographics: a review publication of the Radiological Society of North America, Inc 32 (7):2071–2099. https://doi.org/10.1148/rg.327125146

75.

Reisch N, Rottenkolber M, Greifenstein A, Krone N, Schmidt H, Reincke M, Schwarz HP, Beuschlein F (2013) Testicular adrenal rest tumors develop independently of long-term disease control: a longitudinal analysis of 50 adult men with congenital adrenal hyperplasia due to classic 21-hydroxylase deficiency. The Journal of clinical endocrinology and metabolism 98 (11):E1820–1826. https://doi.org/10.1210/jc.2012-3181 CrossRefPubMed

76.

Hernanz-Schulman M, Brock JW, 3rd, Russell W (2002) Sonographic findings in infants with congenital adrenal hyperplasia. Pediatric radiology 32 (2):130–137. https://doi.org/10.1007/s00247-001-0592-4 CrossRefPubMed

77.

McGeoch SC, Olson S, Krukowski ZH, Bevan JS (2012) Giant bilateral myelolipomas in a man with congenital adrenal hyperplasia. The Journal of clinical endocrinology and metabolism 97 (2):343–344. https://doi.org/10.1210/jc.2011-2373 CrossRefPubMed

78.

Chakraborty RK, Sharma S (2018) Pulmonary Sequestration. In: StatPearls. StatPearls Publishing StatPearls Publishing LLC., Treasure Island (FL),

79.

Zhang N, Zeng Q, Chen C, Yu J, Zhang X (2018) Distribution, diagnosis, and treatment of pulmonary sequestration: Report of 208 cases. Journal of pediatric surgery. https://doi.org/10.1016/j.jpedsurg.2018.08.054 CrossRefPubMedPubMedCentral

80.

Pumberger W, Moroder W, Wiesbauer P (2001) Intraabdominal extralobar pulmonary sequestration exhibiting cystic adenomatoid malformation: prenatal diagnosis and characterization of a left suprarenal mass in the newborn. Abdominal imaging 26 (1):28–31CrossRef

81.

Curtis MR, Mooney DP, Vaccaro TJ, Williams JC, Cendron M, Shorter NA, Sargent SK (1997) Prenatal ultrasound characterization of the suprarenal mass: distinction between neuroblastoma and subdiaphragmatic extralobar pulmonary sequestration. Journal of ultrasound in medicine: official journal of the American Institute of Ultrasound in Medicine 16 (2):75–83CrossRef

82.

Roberts AS, Shetty AS, Mellnick VM, Pickhardt PJ, Bhalla S, Menias CO (2016) Extramedullary haematopoiesis: radiological imaging features. Clinical radiology 71 (9):807-814. https://doi.org/10.1016/j.crad.2016.05.014 CrossRefPubMed

83.

Zhu G, Wu X, Zhang X, Wu M, Zeng Q, Li X (2012) Clinical and imaging findings in thalassemia patients with extramedullary hematopoiesis. Clinical imaging 36 (5):475–482. https://doi.org/10.1016/j.clinimag.2011.11.019 CrossRefPubMed

84.

Georgiades CS, Neyman EG, Francis IR, Sneider MB, Fishman EK (2002) Typical and atypical presentations of extramedullary hemopoiesis. AJR American journal of roentgenology 179 (5):1239–1243. https://doi.org/10.2214/ajr.179.5.1791239 CrossRefPubMed

Title: Imaging features of adrenal gland masses in the pediatric population
Authors: Abdelrahman K. Hanafy
Bilal Mujtaba
Alicia M. Roman-Colon
Khaled M. Elsayes
Douglas Harrison
Nisha S. Ramani
Steven G. Waguespack
Ajaykumar C. Morani
Publication date: 01-04-2020
Publisher: Springer US
Keywords: Magnetic Resonance Imaging
Ultrasound
Magnetic Resonance Imaging
Computed Tomography
Adrenal Cancer
Computed Tomography
Neuroblastoma
Neuroblastoma
Adrenal Cancer
Ultrasound
Published in: Abdominal Radiology / Issue 4/2020
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI: https://doi.org/10.1007/s00261-019-02213-x

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2020

Adrenocortical hyperplasia: a review of clinical presentation and imaging

Breath-hold compressed-sensing 3D MR cholangiopancreatography compared to free-breathing 3D MR cholangiopancreatography: prospective study of image quality and diagnostic performance in pancreatic disorders

Can conventional DWI accurately assess the size of endometrial cancer?

Imaging findings of infectious and inflammatory diseases of the urinary system mimicking neoplastic diseases

Inferior vena cava obstruction in Budd-Chiari syndrome: a comparative study of rapid quantitative phase-contrast MRI and MRV

Missing duct sign

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage